Search

everythinglearnresearchcommunity

for

Search:↓

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Insulin resistance and nesfatin-1 are linked to acne severity.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Young women with PCOS and no other heart risk factors have normal heart function.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

High BMI worsens hair growth in women with PCOS.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

PCOS causes inflammation regardless of body weight.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.